Rion
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · Japan · 501-1,000 Employees
View Company Info for Free
Overview
Headquarters
3-20-41 Higashimotomachi, Kokubunji, Tok...Phone Number
+81 423597099Website
www.rion.co.jpRevenue
$162.1 MillionStock Symbol
6823Industry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
1
1
1
About Rion
Rion started to manufacture crystal elements for acoustic equipments and their applied products, as the first manufacture of such products in Japan. After that, Kobayasi-riken started to manufacture and sell the first hearing instruments in Japan with aiming to solve the stress for hearing-impaired people and to make their speech communication better. "Rionet" hearing instruments, as the brand name of Rion hearing instruments, have been familiar and popular and keep on taking top market share in Japan. It also spreads such network worldwide. In 1960, Kobayasi-riken changed its name to Rion, which derived from Ri of Rigaku meaning science + On from Onkyogaku meaning acoustics. In addition to hearing instruments, Rion provides wide range of products to various fields. Medical instruments typified by audiometers are used in the field of otolaryngology. Sound and vibration measuring instruments are demanded by government agencies and industries to protect environment and quality in manufacRead more
Rion Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Rion your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Rion has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Rion launches new products
Click to see if Rion had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Rion is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Rion
Earning: See what the market has to say on Rion recently announced quarterly report
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Rion has new funding data
Rion, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Find VP level buyers at Rion
Find 3 more new buyers
Company Profile Activity
Activity Insights
Rion is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Rion is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Rion.
Rion Tech Stack
A closer look at the technologies used by Rion
Most Recent Scoops
Event
Events
Open Position
Event
will be attending the SEMICON West 2022 HYBRID conference as an exhibitor. The event occurs from July 12 to July 14, 2022.
Event
Rion News & Media
RION Announces First Patient Enrolled in Phase 1b Clinical Study Evaluating Purified Exosome Product™ (PEP™) for Knee Osteoarthritis
ROCHESTER, Minn.--(BUSINESS WIRE)--RION, a clinical-stage regenerative medicine company at the forefront of exosome-based therapeutics, today announced the enrollment of the first patient in its Phase 1b clinical study evaluating Purified Exosome Product™ (PEP™) for the treatment of Knee Osteoarthritis (OA). This milestone highlights RION’s commitment to advancing innovative regenerative therapies that address unmet medical needs. Knee Osteoarthritis is the most common form of arthritis, affectRION Announces Final Patient Enrolled in the Phase 2 Clinical Study for Purified Exosome Product™ (PEP™) in Diabetic Foot Ulcers
ROCHESTER, Minn.--(BUSINESS WIRE)--RION, a clinical-stage regenerative medicine company at the forefront of exosome-based therapeutics, announced today that it has completed patient enrollment in its Phase 2 clinical trial for Purified Exosome Product™ (PEP™) in the treatment of Diabetic Foot Ulcers (DFUs). This milestone marks a significant step forward in the company’s mission to develop cutting-edge therapies addressing chronic wound care. The multi-center, prospective, open-label study enroRION Expands Leadership Team with the Appointment of Five Renowned Experts to Advisory Boards
ROCHESTER, Minn.--(BUSINESS WIRE)--RION, a clinical-stage regenerative medicine company pioneering exosome-based therapeutics, today announced the appointment of five distinguished leaders to its Advisory Board. These new advisors bring decades of expertise in their respective fields, ranging from orthopedic & plastic surgery to infectious diseases, military medicine, biomanufacturing and government health strategy, further positioning RION as a leader in innovative regenerative medicine. “RION Announces Initiation of Phase 1b Clinical Study to Evaluate Purified Exosome Product™ (PEP™) for Knee Osteoarthritis
ROCHESTER, Minn.--(BUSINESS WIRE)--RION, at the forefront of exosome innovation and therapeutic application, has officially commenced a Phase 1b study aimed at assessing the efficacy and safety of Purified Exosome Product™ (PEP™), its exclusive exosome regenerative therapeutic, for the management knee osteoarthritis (Knee OA). Each year, Knee OA affects approximately 364 million people worldwide and is associated with over one million hospitalizations annually in the U.S., primarily for total j
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Rion
Sign Up For FreeTo access detailed company insights
Rion started to manufacture crystal elements for acoustic equipments and their applied products, as the first manufacture of such products in Japan. After that, Kobayasi-riken started to manufacture and sell the first hearing instruments in Japan with aiming to solve the stress for hearing-impaired people and to make their speech communication bett... Read More
